Simpson Curran bought RGNX
December 31, 2025 · Form 4 insider transaction
Simpson Curran bought 951 shares of REGENXBIO Inc. at $7.00 per share, a transaction worth $6.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 187 days after the transaction.
Direction
Acquired (buy-side)
Shares
951
Price
$7.00
Total value
$6.7K
InsiderSimpson Curran
RoleOfficer, Director
CompanyREGENXBIO Inc. (RGNX)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJuly 6, 2026
Shares owned after343,418
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is exempt under Rule 16b-3(c).; In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 1, 2025.